IRCT2014061118061N1 IRCT 2014-10-20 Behin Tamin Rosamed Co. A therapeutic and side effects comparison between domestic type and the similar brand in gastric cancer. A therapeutic and side effects comparison between Rosastim and Brand type (Neupogen) in gastric cancer 2013-04-20 anticipated 60 Complete https://irct.ir/trial/16482 interventional Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Health service research. N/A Gasteric cancer. Intervention 1: Neupogen prefilled syringe 300 microgram per 0.5 mL is as a control group, duration of treatment for each patient is about six months. blood sampling is done consecutive days, then one day is rest, after that sampling is done every other day. this process repeats triweekly till eight times. Intervention 2: Rosastim 300ug/0.5mL is a subcutaneous prefilled syringe. duration of treatment for each patient is about six months. blood sampling is done consecutive days, then one day is rest, after that sampling is done every other day. this process repeats triweekly till eight times.